FDA Investigator Helen J Hamaoka
Helen J Hamaoka has inspections in 4 countries as of 07 Nov 2023. Helen J Hamaoka has collaborated with a combinined 4147 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
455
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Guatemala,
Japan
Co-Investigator(s):
Adam S Freeman,
Alethea M Aranas,
Alex G Kalugin,
Alexandra B Pitkin,
Alice A Blair,
Andersoneric,
Andrew E Kay,
Angel K Sandhu,
Angela D Wise,
Anna J Vickrey,
Anna L Marroquin,
Anna L Viveros Hernandez,
Anthony E Keller, RPh,
Ashar P Parikh,
Baker,
Belinda E Clifton,
Benny Y Gong,
Blair,
Brandi N Mcgrady,
Brandon Adcock,
Breena L D'ambrogi,
Brenda K Alford,
Brian P Hendrickson,
Brian R Henderson,
Brian R Yaun,
Bryce A May,
Carl Lee,
Carol A Elems,
Carr,
Carr Sharpe,
Carrie E Thrasher,
Celena Ngo,
Celeste K Wong,
Chan,
Chloe Anne K Le,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Clara E Santiago,
Courtney R Bolton,
Courtney R Warren,
Cristina Resendiz Navarrete,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel J Munoz,
Daniel J Roberts,
Daniel Velasquez,
David A Laplante,
David A Lum,
David G Eng,
David J Leray,
Davina M Martinez,
Deborah K Richardson,
Deborah Kleinfeld,
Edna J Hidalgo,
Edward D Harris,
Edward R Schiffman,
Edwards,
Elizabeth C Ajuzie,
Elizabeth P Mayer,
Elodie Xtong Lin,
Elva M Centeno,
Elva M Ibarra,
Emal Wahab,
Emil P Wang, JD,
Emmanuel O Kerry,
Eric J Heinze,
Eric Maddox,
Erica L Nicoll,
Erica R Pomeroy,
Estefania Fernandez,
Frank P Bianco,
Gary L Hartman,
Gillenwater,
Gina M Hall,
Grant L Davis,
Greg K Keshishyan,
Gulshan R Anand,
Helen J Mamaoka,
Herbert E Arden,
Humberto Z Gomez,
Huy T Pham,
Ingrid A Zambrana,
Isabel Y Espinosa,
Ismael Garibay,
James C Lee, PharmD,
James C Yee,
Jane Chen,
Janice K Gardner,
Janice R Small,
Janice Wai,
Jazmine M Welcher,
Jeanmaire Hryshko,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer S King,
Jessica B Clark,
Jessica B Darneille,
Jessica B Zachman,
Joan T Briones,
Joanna M Fukuda,
Joanne M Fukuda,
Jocelyn T Ramos,
Johannes S Corley,
John A Gonzalez,
John A Liu,
John Fox,
Jolene S Hedgecock,
Jonathan K Dare,
Jonathan M Mcbride,
Jorge L Bertran,
Joseph A Seitz,
Joseph M Willems,
Joseph Tibay,
Juliane Kjung Lau,
Kacie M Crowther,
Karen Bak,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Karl D Hezel,
Karla J Gibler,
Karla K Gibler,
Katie T Duong,
Kawshalya Pathiraja,
Kelvin X Sanders,
Keren Arkin,
Kevin P Foley,
Kevin T Gerrity,
Kimberlee Wood,
Kimberly L Anderson,
Kimberly L Pruszko,
Kristen E Szenderski,
Larkin R Buckalew,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Lee,
Leongc,
Lester O Boian,
Ligia M Cline,
Ligia M Sanders,
Lija V Fellows,
Lili M Carr,
Lillian C Lopez,
Linda S Shook,
Lisa H Nakagawa,
Liu,
Lopez,
Lorenzo F Edwards,
Lorraine N Dixon,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lt Stevenm Galvez,
Lucila B Nwatu,
Lydia S Chan,
Lynda L Perry, PhD,
Lyndsey G Smith,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Maridali De Leon Torres,
Mario R Velasquez,
Marjorie D Santos,
Mark E Baldwin,
Mary C Acton,
Mary C Wall,
Mary Ewilkerson Brinsko,
Mary T Carden,
Matthew A Walburger,
Mcgrewp,
Melody M Ragasa Leong,
Michael Davila,
Michael S Call,
Michelle L Orner,
Michelle L Tripp,
Min Shanmabel Liu,
Monique C Lo,
Nianna C Burns,
Nicole Yuen,
Nympha V Florendo,
Orval D Mcintire,
Paola E Lathrop,
Patrick E Gainer,
Paula E Davis Debella,
Peter E Baker,
Phillip J Sample,
Phillip L Toy,
Phung,
Quynh H Strandberg,
Rachel J Cantrell,
Randall F Albright,
Randall J Plunkett,
Randall P Zielinski,
Randy L Elsberry,
Raymond Souweha,
Rebecca E Sulpacio,
Richard L Bartlett,
Richard M Jacobs,
Richard W Tubb,
Robert J Waldorf,
Robert P Neligan,
Robles,
Rocio Guzman Velazquez,
Roger D Gawne,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sandra S Saniga,
Sara Jdent Acosta,
Sara M Richardson,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Seyyida Saterfield,
Shelley H Beausoleil,
Shelley H Roberts,
Sherri J Jackson,
Siobhan A Gallagher,
Sondra R Davis,
Sparky L Bartee,
State Agency,
Steve P Yost,
Steven B Chiu,
Steven C Himebaugh,
Steven J Branch,
Steven M Galvez,
Stuart Kim,
Stuart W Russell,
Suzanne M Crotty,
Teresa I Navas,
Terrence Gee,
Thomas A Heller,
Thomas Cote,
Thomas N Adjabeng,
Thomas W Gordon,
Timothy C Grome,
Tomanik'e C Banks,
Travelle D Mason,
Tristian E Strait,
Uduak M Inokon,
Victoria L Morgan,
Victoria Taylor,
Wayne L Jefferson,
William J Foust,
William J Weis,
Yen Tso Kuo,
Zachary R Harris
Helen J Hamaoka's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more